2nd Quarter - Report

SQUIRE PATTON BOGGS for PFIZER INC

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

American Recovery and Reinvestment Act (PL 111-5); Promoting Innovation and Access to Life-Saving Medicine Act (HR 1427/S 726); Pathway for Biosimilars Act (HR 1548); Patient-Centered Outcomes Research Act of 2009 (S 1213); Comparative Effectiveness Research Act of 2009 (HR 2502); Doctor-Patient Relationship and Research Protection Act (HR 2824); Protecting Consumer Access to Generic Drugs Act of 2009 (HR 1706); Food and Drug Administration Globalization Act of 2009 (HR 759); Drug and Device Accountability Act of 2009 (S 882); Pharmaceutical Market Access and Drug Safety Act of 2009 (HR 1298/S 1232)

LobbyistCovered position, as disclosed
JOHN JONAS —
MATTHEW TODD TUTEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2824 (111th), H.R. 759 (111th), H.R. 1298 (111th), H.R. 1548 (111th), H.R. 2502 (111th), H.R. 1706 (111th), H.R. 1427 (111th)

Medicare/Medicaid MMM

Medicare Prescription Drug Savings and Choice Act (S333/HR 684); Medicaid Prescription Drug Rebate Equalization Act of 2009 (HR 904); Drug Rebate Equalization Act of 2009 (S 547); Voluntary State Discount Prescription Drug Plan Act of 2009 (HR 1725); Affordable Health Care Choices Act (no # yet)

LobbyistCovered position, as disclosed
JOHN JONAS —
MATTHEW TODD TUTEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1725 (111th), H.R. 684 (111th), H.R. 904 (111th)

Labor Issues/Antitrust/Workplace LBR

Issues related to possible merger of Pfizer and Wyeth

LobbyistCovered position, as disclosed
JONATHAN YAROWSKY GCHouseJudCom82-95; SACPres95-98

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.